Circulating RANKL and RANKL mRNA Levels in Osteoarthritic Males
Author Information
Author(s): David Findlay, Mellick Chehade, Helen Tsangari, Susan Neale, Shelley Hay, Blair Hopwood, Susan Pannach, Peter O'Loughlin, Nicola Fazzalari
Primary Institution: University of Adelaide
Hypothesis
The study aimed to measure serum levels of RANKL and OPG and their corresponding levels in bone mRNA in humans.
Conclusion
This study is the first to show a relationship between serum RANKL and the expression of RANKL mRNA in bone.
Supporting Evidence
- Serum RANKL levels were negatively related to age in men.
- RANKL mRNA levels in bone were positively related to age in men.
- Significant negative correlation between serum RANKL levels and RANKL mRNA levels in bone.
Takeaway
The study found that in men with osteoarthritis, higher levels of RANKL mRNA in bone are linked to lower levels of RANKL in the blood.
Methodology
Fasting blood samples and bone samples were collected from patients undergoing hip replacement surgery, and RANKL and OPG levels were measured using ELISA and RT-PCR.
Potential Biases
Potential bias due to the exclusion of individuals with metabolic bone diseases.
Limitations
The study's findings may not be generalizable to women or younger populations.
Participant Demographics
15 men aged 50 to 79 years and 25 women aged 47 to 87 years.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website